CAXTON CORP - Q2 2021 holdings

$146 Million is the total value of CAXTON CORP's 63 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 11.6% .

 Value Shares↓ Weighting
SBBP  STRONGBRIDGE BIOPHARMA PLC$24,008,000
+7.6%
8,083,4420.0%16.45%
+13.5%
MTEM BuyMOLECULAR TEMPLATES INC$16,719,000
-37.6%
2,137,991
+0.7%
11.46%
-34.2%
CRDF BuyCARDIFF ONCOLOGY INC$15,583,000
-20.4%
2,343,333
+10.8%
10.68%
-16.1%
SCYX BuySCYNEXIS INC$10,956,000
-2.0%
1,488,623
+5.7%
7.51%
+3.4%
SVRA BuySAVARA INC$10,117,000
-15.4%
5,951,015
+3.5%
6.93%
-10.8%
KALA BuyKALA PHARMACEUTICALS INC$9,036,000
-6.2%
1,704,849
+19.2%
6.19%
-1.1%
SRRA  SIERRA ONCOLOGY INC$8,645,000
+13.0%
443,9590.0%5.92%
+19.2%
GLD  SPDR GOLD TR$6,761,000
+3.5%
40,8200.0%4.63%
+9.2%
RZLT  REZOLUTE INC$6,054,000
+102.1%
424,2430.0%4.15%
+113.3%
CTIC SellCTI BIOPHARMA CORP$5,786,000
-20.9%
2,314,533
-8.0%
3.96%
-16.6%
ADXN  ADDEX THERAPEUTICS LTDsponsored ads$2,542,000
-9.0%
265,9400.0%1.74%
-4.0%
LUXA  LUX HEALTH TECH ACQUISITION$1,978,000
-3.7%
200,0000.0%1.36%
+1.6%
AACU SellARES ACQUISITION CORPORATIONunit 99/99/9999$1,397,000
-1.6%
139,680
-1.6%
0.96%
+3.8%
ISEE BuyIVERIC BIO INC$1,284,000
+40.9%
203,414
+38.0%
0.88%
+48.6%
EIGR BuyEIGER BIOPHARMACEUTICALS INC$1,181,000
+41.8%
138,626
+47.3%
0.81%
+49.5%
GOOG BuyALPHABET INCcap stk cl c$933,000
+110.1%
372
+73.8%
0.64%
+121.9%
INTU BuyINTUIT$924,000
+123.2%
1,885
+74.5%
0.63%
+135.3%
FB BuyFACEBOOK INCcl a$892,000
+105.5%
2,566
+74.0%
0.61%
+116.7%
PYPL BuyPAYPAL HLDGS INC$892,000
+108.9%
3,060
+74.2%
0.61%
+120.6%
CVNA BuyCARVANA COcl a$872,000
+100.0%
2,888
+74.0%
0.60%
+111.0%
CDLX BuyCARDLYTICS INC$864,000
+107.7%
6,805
+79.4%
0.59%
+119.3%
MCO BuyMOODYS CORP$863,000
+112.0%
2,382
+74.9%
0.59%
+123.9%
SPGI BuyS&P GLOBAL INC$851,000
+103.1%
2,073
+74.3%
0.58%
+114.3%
MSFT BuyMICROSOFT CORP$829,000
+100.7%
3,059
+74.7%
0.57%
+111.9%
V BuyVISA INC$822,000
+92.5%
3,516
+74.2%
0.56%
+103.2%
TDG BuyTRANSDIGM GROUP INC$802,000
+92.3%
1,239
+74.5%
0.55%
+102.6%
MA BuyMASTERCARD INCORPORATEDcl a$798,000
+77.7%
2,185
+73.4%
0.55%
+87.3%
AMT BuyAMERICAN TOWER CORP NEW$782,000
+98.5%
2,896
+75.7%
0.54%
+109.4%
DIS BuyDISNEY WALT CO$773,000
+64.8%
4,400
+73.0%
0.53%
+73.8%
CHTR BuyCHARTER COMMUNICATIONS INC Ncl a$766,000
+105.4%
1,062
+75.8%
0.52%
+116.9%
WHR BuyWHIRLPOOL CORP$761,000
+71.8%
3,490
+73.8%
0.52%
+80.9%
MDLZ BuyMONDELEZ INTL INCcl a$752,000
+86.6%
12,046
+75.1%
0.52%
+96.6%
FICO BuyFAIR ISAAC CORP$747,000
+80.4%
1,486
+74.6%
0.51%
+90.3%
CRM BuySALESFORCE COM INC$730,000
+103.9%
2,988
+76.8%
0.50%
+114.6%
NFLX BuyNETFLIX INC$697,000
+77.8%
1,319
+75.4%
0.48%
+87.5%
BTWN  BRIDGETOWN HOLDINGS LTD$634,000
-6.8%
62,6880.0%0.43%
-1.8%
FLAC  FRAZIER LIFESCIENCES ACQU CO$625,000
-1.9%
64,0000.0%0.43%
+3.4%
SSAAU  SCIENCE STRATEGIC ACQ ALPHAunit 01/20/2026$616,0000.0%62,0000.0%0.42%
+5.5%
HMCOU SellHUMANCO ACQUISITION CORPunit 12/08/2023$598,000
-33.7%
57,724
-32.5%
0.41%
-30.0%
ELEV NewELEVATION ONCOLOGY INC$537,00039,586
+100.0%
0.37%
AJAX SellAJAX I$498,000
-55.1%
50,000
-53.7%
0.34%
-52.6%
GIGGU  GIGCAPITAL4 INCunit 99/99/9999$460,000
+3.6%
45,0000.0%0.32%
+9.4%
ONCS BuyONCOSEC MED INC$449,000
-18.8%
159,935
+38.0%
0.31%
-14.2%
SWBKU  SWITCHBACK II CORPORATIONunit 99/99/9999$395,000
-0.5%
39,0000.0%0.27%
+5.0%
BOASU  BOA ACQUISITION CORPunit 99/99/9999$338,0000.0%34,0700.0%0.23%
+5.5%
SVFA  SVF INVESTMENT CORP$276,000
-3.2%
27,9000.0%0.19%
+2.2%
ISOSU  ISOS ACQUISITION CORPORATIONunit 99/99/9999$245,000
+2.5%
24,0000.0%0.17%
+8.4%
PV  PRIMAVERA CAPITAL ACQUIST CO$234,000
-0.4%
24,0000.0%0.16%
+4.6%
SCOAU SellSCION TECH GROWTH Iunit 12/17/2025$227,000
-61.4%
22,410
-61.7%
0.16%
-59.2%
PICCU  PIVOTAL INVESTMENT CORP IIIunit 01/28/2028$168,0000.0%16,8000.0%0.12%
+5.5%
HLXA  HELIX ACQUISITION CORP$165,000
+1.2%
16,0090.0%0.11%
+6.6%
SRNGU SellSOARING EAGLE ACQUISITION COunit 02/23/2026$159,000
-56.3%
15,000
-58.3%
0.11%
-53.8%
ALDX SellALDEYRA THERAPEUTICS INC$134,000
-61.8%
11,784
-60.1%
0.09%
-59.6%
AJAXWS  AJAX I*w exp 10/27/202$117,000
+10.4%
62,5000.0%0.08%
+15.9%
RTP  REINVENT TECHNOLOGY PARTNERScl a$110,000
-1.8%
11,0000.0%0.08%
+2.7%
NGAC  NEXTGEN ACQUISITION CORPcl a$109,0000.0%11,0000.0%0.08%
+5.6%
RMGCU  RMG ACQUISITION CORP IIIunit 02/08/2026$110,000
+0.9%
11,0000.0%0.08%
+5.6%
DGNR  DRAGONEER GROWTH OPPORTUN CO$110,000
-1.8%
11,0000.0%0.08%
+2.7%
LUXAW  LUX HEALTH TECH ACQUISITION*w exp 11/30/202$90,000
-9.1%
66,6660.0%0.06%
-3.1%
BTWNW  BRIDGETOWN HOLDINGS LTD*w exp 09/30/202$83,000
-28.4%
39,7730.0%0.06%
-24.0%
MRACW SellMARQUEE RAINE ACQUISITION CO*w exp 12/01/202$29,000
-12.1%
23,171
-12.1%
0.02%
-4.8%
FLACW  FRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202$26,000
+36.8%
21,3330.0%0.02%
+50.0%
PVWS  PRIMAVERA CAPITAL ACQUIST CO*w exp 01/19/202$13,000
+30.0%
12,0000.0%0.01%
+50.0%
VGAC ExitVG ACQUISITION CORP$0-11,000
-100.0%
-0.07%
SPRQ ExitSPARTAN ACQUISITION CORP II$0-11,000
-100.0%
-0.08%
HEC ExitHUDSON EXECUTIVE INVT CORP$0-25,000
-100.0%
-0.16%
FTOC ExitFTAC OLYMPUS ACQUISITION COR$0-25,000
-100.0%
-0.17%
GMIIU ExitGORES METROPOULOS II INCunit 01/31/2028$0-32,000
-100.0%
-0.21%
PTMN ExitPORTMAN RIDGE FIN CORP$0-293,144
-100.0%
-0.41%
MRAC ExitMARQUEE RAINE ACQUISITION CO$0-105,500
-100.0%
-0.68%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLECULAR TEMPLATES INC24Q2 202330.7%
STRONGBRIDGE BIOPHARMA PLC22Q3 202173.1%
GARRISON CAP INC18Q3 20209.9%
BERKSHIRE HATHAWAY INC DEL17Q3 20195.8%
EIGER BIOPHARMACEUTICALS INC17Q3 20221.7%
AGILE THERAPEUTICS INC16Q1 201855.5%
KALA PHARNACEUTICALS INC16Q4 202117.6%
CM FIN INC16Q1 20197.8%
SYNTA PHARMACEUTICALS CORP15Q2 201699.9%
CTI BIOPHARMA CORP14Q4 20218.7%

View CAXTON CORP's complete holdings history.

Latest significant ownerships (13-D/G)
CAXTON CORP Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Addex Therapeutics Ltd.February 14, 2023718,8490.9%
Cardiff Oncology, Inc.February 14, 2023983,6072.2%
Rezolute, Inc.February 14, 20231,860,5185.0%
Xeris Biopharma Holdings, Inc.February 14, 20235,973,3244.4%
CTI BIOPHARMA CORPFebruary 14, 20222,239,3002.3%
Sierra Oncology, Inc.February 14, 20221,119,3227.0%
Strongbridge Biopharma plcSold outJanuary 05, 202200.0%
SUNESIS PHARMACEUTICALS INCSold outFebruary 16, 202100.0%
Alcentra Capital CorpFebruary 14, 20201,005,0007.8%
Garrison Capital Inc.February 14, 20201,223,0967.6%

View CAXTON CORP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14

View CAXTON CORP's complete filings history.

Compare quarters

Export CAXTON CORP's holdings